Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diltiazem vs Nifedipine for Chronic Anal Fissure
NCT04887818Phase 3Unknown
- Sponsor
- University of Calgary
- Start
- Jun 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of DOLIZEM in chronic anal fissure (CAF), sponsored by University of Calgary. Status: unknown.
02
Drugs
DOLIZEM
03
Conditions
chronic anal fissure (CAF)
Beyond the preview
Go deeper on NCT04887818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04887818.